AdvanSix Inc. (ASIX) Aandelenanalyse

Bedrijfsoverzicht

AdvanSix Inc. is an integrated chemistry company that specializes in the manufacture and sale of polymer resins across the United States and international markets. The firm's primary product offering includes Nylon 6, a synthetic polymer resin utilized to produce fibers, filaments, engineered plastics, and films, which serves as a foundational material for various industrial applications. Operating within the Basic Materials sector and specifically the Chemicals industry, the company functions as a key supplier of essential industrial inputs where volatility in raw material costs and demand cycles can significantly impact operational dynamics. The company currently holds a market capitalization of $643.34M and generates annual revenue of $1.52B, supporting a workforce of 1410 employees. These valuation and revenue figures position AdvanSix as a mid-cap entity with a relatively modest enterprise size compared to large-cap industrial peers, suggesting a balance sheet that may be more sensitive to margin compression and capital expenditure requirements inherent in the chemical manufacturing landscape.

Financiële gezondheid

AdvanSix reported total revenue of $1.52B over the trailing twelve months, accompanied by a net income of $49.29M and an EBITDA of $139.93M. The significant disparity between the $1.52B in revenue and the $49.29M in net income highlights a cost structure where operating expenses, including depreciation, interest, and other overhead costs, consume approximately $1.47B of gross profit before reaching the bottom line. The company generated a free cash flow of -$19,318,876 during the period, indicating a current cash burn that limits immediate financial flexibility for share buybacks or aggressive debt reduction without external financing. Despite the negative cash flow, the balance sheet maintains $19.77M in cash against $382.69M in total debt, resulting in a debt-to-equity ratio of 46.94 which reflects a leveraged capital structure typical for capital-intensive industries. This leverage is further contextualized by a profit margin of 3.2%, a gross margin of 10.8%, and an operating margin of -0.3%, where the negative operating margin suggests that fixed cost absorption or specific operational inefficiencies are currently erding profitability before tax and interest effects. Liquidity is assessed via a current ratio of 1.13, indicating that the company possesses just enough current assets to cover short-term liabilities, leaving little room for error in working capital management. Return on equity stands at 6.2% while return on assets is 2.3%, metrics that reveal management effectiveness is currently constrained by the high asset base and debt load required to generate modest absolute returns.

Waarderingsbeoordeling

The stock trades with a trailing P/E ratio of 13.30 and a forward P/E of 8.43, a divergence that implies the market expects earnings to expand significantly in the coming years to justify the lower forward multiple. The price-to-book ratio is 0.79, suggesting that the market values the company at a discount to its tangible book value, which often signals that investors are pricing in potential downside risks or a cyclical downturn in the chemical sector. Alternative valuation metrics such as a price-to-sales ratio of 0.42 and an EV/EBITDA of 7.19 provide further perspective, indicating the company is valued cheaply relative to sales and earnings before interest, taxes, depreciation, and amortization, though these multiples must be viewed alongside the low absolute returns. Price action over the last year has seen the stock range between a 52-week low of $14.10 and a 52-week high of $25.94, with the current trading price sitting at approximately 55.9% below the 52-week high and 25.9% above the 52-week low. The beta of 1.43 indicates that the stock exhibits higher volatility than the broader market, meaning price swings will likely be more pronounced during periods of market stress or rallies compared to large-cap blue-chip stocks.

Growth & Income

Revenue growth for the trailing twelve months stands at 9.4%, while earnings growth is listed as N/A, suggesting that the top-line expansion has not yet translated into proportional bottom-line improvement or that earnings data for the specific period used for growth comparison is unavailable. The company pays a dividend with a yield of 2.7% and maintains a payout ratio of 35.6%, a level that appears sustainable given the current earnings generation, although the negative free cash flow creates some pressure on the ability to fund these payments from internal operations alone. Since the earnings growth rate is not quantified, it is impossible to determine if earnings are growing faster or slower than revenue, but the 9.4% revenue increase does indicate a successful expansion of market share or pricing power in the polymer resin space. The overall growth and income profile presents a mixed picture of solid top-line momentum supported by a consistent dividend, yet tempered by negative operating cash flow and a leveraged balance sheet that requires careful monitoring of interest rate environments.